Researching new methods of screening for adverse pregnancy outcome: Lessons from pre-eclampsia

PLoS Medicine

Volumn 9, Issue 7, 2012, Pages

  Smith, Gordon C S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ARTICLE; CLINICAL ASSESSMENT; GESTATIONAL AGE; HUMAN; LASER DOPPLER FLOWMETRY; LOW DRUG DOSE; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; RISK; SCREENING; STILLBIRTH; TROPHOBLAST; UTERINE ARTERY;

CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MASS SCREENING; PLACENTA; POVERTY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME;

EID: 84864450277     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001274     Document Type: Article

References (13)

1. World Health Organization (2011) World health statistics 2011. Geneva: WHO Press.
2. National Collaborating Centre for Women's and Children's Health (2008) NICE guideline: antenatal care. London: RCOG Press.
3. Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KH, ((2005)) An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol 193:: 429--436.
4. Alfirevic Z, Stampalija T, Gyte GM, ((2010)) Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database Syst Rev (8) pp. CD001450.
5. National Collaborating Centre for Women's and Children's Health (2011) NICE guideline: hypertension in pregnancy. London: RCOG Press.
6. Duley L, Henderson-Smart DJ, Meher S, King JF, ((2007)) Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev (2) pp. CD004659.
7. Churchill D, Duley L, ((2002)) Interventionist versus expectant care for severe pre-eclampsia before term. Cochrane Database Syst Rev (3) pp. CD003106.
8. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, et al. ((2009)) Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 374:: 979--988.
9. Liu S, Joseph KS, Liston RM, Bartholomew S, Walker M, Leon JA, et al. ((2011)) Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 118:: 987--994.
10. Tuffnell DJ, Jankowicz D, Lindow SW, Lyons G, Mason GC, Russell IF, et al. ((2005)) Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG 112:: 875--880.
11. Smith GC, ((2010)) First-trimester determination of complications of late pregnancy. JAMA 303:: 561--562.
12. Lawn JE, Blencowe H, Pattinson R, Cousens S, Kumar R, Ibiebele I, et al. ((2011)) Stillbirths: where? when? why? How to make the data count? Lancet 377:: 1448--1463.
13. Smith GC, Shah I, White IR, Pell JP, Crossley JA, et al. ((2007)) Maternal and biochemical predictors of antepartum stillbirth among nulliparous women in relation to gestational age of fetal death. BJOG 114:: 705--714.